Objective: The factors involved in restenosis after balloon angioplasty are poorly characterized but the local concentration of the Ž . potent mitogens angiotensin II AII and thrombin is known to be increased at sites of vascular injury. We investigated the possibility of a synergistic interaction between AII and thrombin by studying the effects of AII on the expression of the thrombin receptor in rat aortic Ž . smooth muscle cells VMSC . Methods: Thrombin receptor mRNA expression was studied by Northern blot analysis and RT-PCR using total RNA extracted from VMSC or from endothelium-denuded rat aortae. As a measure of thrombin receptor protein expression, we assessed either the thrombin-stimulated release of 6-keto-prostaglandin F from VMSC or the contraction of endothelium-denuded rat 1a aortic rings. Results: The thrombin receptor mRNA was expressed at a low level in both cultured and native VMSC. AII concentrationand time-dependently increased expression of thrombin receptor mRNA in VSMC and augmented the thrombin-induced release of Ž . 6-keto-prostaglandin F as well as the thrombin-induced contraction. Blockade of the angiotensin subtype 1 AT receptor by EXP3174 1a 1
Introduction

Ž
. Vascular smooth muscle cell VSMC proliferation is influenced by a variety of cytokines and growth factors generated at sites of injury. Indeed, extensive growth and migration of VSMC occurs following the mechanical injury of arteries and the resulting intimal thickening represents a major complication following balloon angioplasty. Similar events have been described during atherogenesis and following coronary artery bypass surgery. Balloon angioplasty of human coronary or canine carotid arteries results in an increase in the expression of angiotensin-con-Ž . verting enzyme ACE , the chymostatin-sensitive AII-gen-) Ž .
Ž . Corresponding author. Tel.: q49 69 6301-6995; Fax: q49 69 6301-7668; E-mail: fisslthaler@em.uni-frankfurt.de w x erating enzyme 1,2 and angiotensinogen in the media and w x neointima 3 , all of which lead to an increase in the local Ž . concentration of angiotensin AII . AII, besides its function as potent vasoconstrictor, has been shown to induce w x hypertrophy in cultured VSMC 4 , and to promote the proliferation and migration of VSMC in the rat arterial w x wall 5 . Inhibition of ACE, or the application of an-Ž . giotensin subtype 1 AT receptor antagonists prior to, or 1 shortly after, angioplasty of the carotid artery has been w x reported to attenuate intimal thickening 6,7 . Moreover, an increased expression of AT receptors has been reported in 1 the media and neointima of balloon-injured rat carotid arteries, supporting the concept that the AII-induced changes are mediated by the activation of this receptor w x subtype 8 . Following disruption of the endothelium, sub-endothelial cell layers are exposed which promote the activation of platelets and the initiation of the coagulation cascade resulting in the formation of thrombin. This serine protease is present in balloon-injured vessels several weeks w x after injury 9 and, as it is a potent mitogen in fibroblasts w x and VSMC 10,11 , has been implicated in the development of atherosclerotic lesions and restenosis. Indeed, neointimal thickening after balloon angioplasty in rabbits was significantly decreased by treatment with heparin or w x hirudin 12,13 .
Cellular responses to thrombin are mediated largely, if not solely, by a receptor which belongs to the superfamily G-protein coupled receptors. Thrombin activates this receptor by proteolytical cleavage of the N-terminal region w x and the new amino terminus is a tethered ligand 8,14 . Stimulation is followed by rapid desensitization via phosphorylation, subsequent internalization and degradation of w x the receptor 15 . Consequently, in the absence of an intracellular store of thrombin receptors which can rapidly replenish the plasma membrane, the expression of the functional thrombin receptor is dependent on its de novo synthesis.
In human atherosclerotic lesions and in balloon-injured rat carotid arteries, an increased expression of the thrombin receptor has been demonstrated using in situ hybridization w x and immunohistochemical techniques 16,17 . This enhanced receptor expression is most probably regulated by factors produced by the vascular wall and by activated platelets in the vicinity of the lesion. Indeed, basic fibrob-Ž . last growth factor bFGF , platelet-derived growth factor AA Ž .w x Ž . w x PDGF 17 and serotonin 5-HT 18 can increase the AA expression of thrombin receptor mRNA. Given the apparent importance of AII in instigating proliferation in injured vessels, we investigated whether AII is also able to increase in expression of the thrombin receptor, which is a potent mitogen in VSMC.
Methods
Materials
Angiotensin II was purchased from Bachem, 2-N- . After reaching confluence, the cells were serially passaged and all experiments were performed using cells from passage 9 and higher. Two days prior to each experiment, the culture medium was replaced with medium Ž . containing bovine serum albumin BSA, 0.1% .
RNA extraction and Northern blotting
Total RNA from cultured VSMC and endothelium-denuded rat aortae was isolated using acid guanidium isothiow x cyanate as described 19 . RNA was spectrophotometrically quantified by the absorbance at 260 nm and equal Ž . amounts of total RNA 20-30 mg were separated on a 1% formaldehyde agarose gel. After transfer onto nylon mem-Ž . branes Amersham, Braunschweig, Germany , the RNA was fixed by UV-crosslinking and baking at 808C for 2 h. Thereafter, filters were prehybridized in TrisrHCl pH 7. 558C . The blots were exposed to X-ray films for 1-4 days at y708C and the optical density of the specific signals Ž was quantified by densitometric analysis ImageMaster . 1D, Pharmacia Freiburg, Germany . The RNA content in each lane was normalized by measuring the intensity of either the ethidium bromide staining or the hybridization signal from the 18S RNA.
RT-PCR
Ž . Equal amounts of total RNA 2 mg from rat aortae Ž were used for reverse transcription Superscript, Gibco, . Life Technology, Heidelberg, Germany using random Ž . hexamers pdN6, Pharmacia as primers. One tenth of the reverse transcription reaction was subjected to PCR analy-Ž . sis 30 cycles, 528C annealing in which the thrombin receptor and glyceraldehyde-3-phosphate dehydrogenase Ž . GAPDH mRNA were co-amplified. The thrombin receptor-specific primers were derived from rat and human Ž sequences Genbank accession numbers M81642 U63331, re sp e c tiv e ly : u p stre a m p rim e r, 5
X CAGAATCTGAGA TrG GAT-3 ; downstream primer, X X . 5 -GACCCGAACTGCCAATCGGT-3 the sequences for GAPDH were derived from the cDNA sequence from rat ŽGenbank accession number X02231 and X00972: upstream primer, 5
X -TATGACAACTCCCTCAAGAT-3 X ; downstream primer, 5
X -AGATCCACAACGGATACATT-X . 3 and the amplified fragments had an expected length of 420 and 320 bp, respectively. The PCR reaction products were subjected to non-denaturing agarose gel electrophoresis, stained with ethidium bromide and the intensity of the fluorescence of the specific bands at 340 nm was quantified by densitometric analysis.
Release of 6-keto-prostaglandin F 1a
Confluent VSMC were incubated in the presence or absence of different concentrations of AII for 6 h. Thereafter, the cells were washed with a HEPES-modified Ty- prostacyclin, released into the supernatant was determined Ž using a specific radioimmunoassay Dupont, Dreieich, . Germany .
Organ bath experiments
Experiments were performed using aortae obtained from Wistar Kyoto rats which were housed in conditions conforming to the Guide for the Care Passive tension was adjusted over a 30-min equilibration period to 2 g; thereafter the segments were exposed to KCl Ž . 80 mmolrl until stable contractions were obtained. A Ž concentration response curve to phenylephrine 1 nmolrl . to 1 mmolrl was determined and the effective removal of the endothelium was assessed by the lack of response to Ž . acetylcholine 1 mmolrl . After washout, the thrombin-in-Ž . duced 5 and 10 Urml increase in vascular tone was measured.
Statistical analysis
Data are expressed as mean " s.e.m. Statistical analysis Ž . was performed by one-way analysis of variance ANOVA followed by a Bonferroni t-test or the two-tailed Student's t-test for paired and unpaired data, where appropriate. A value of P -0.05 was considered statistically significant.
Results
Effect of AII on thrombin receptor mRNA expression
Levels of mRNA encoding the thrombin receptor were determined by Northern blot analysis using total RNA isolated from confluent cultures of VSMC. Treatment of Ž . VSMC with AII 1 mmolrl increased expression of Ž . thrombin receptor mRNA Fig. 1 . Maximal expression of Ž . thrombin receptor mRNA 3-fold over basal level was observed 2 h after stimulation with AII and returned to . h with AII showed no secondary increase in the thrombin Ž . receptor mRNA level data not shown . Therefore, all of the following Northern blot experiments were performed using cells incubated with AII for 2 h. The effect of AII on the expression of the thrombin receptor was concentration-dependent with an increase in thrombin re- 
Effect of AII receptor antagonists
To characterize the AII receptor mediating the AII-induced increase in thrombin receptor mRNA quiescent Ž VSMC were treated with preferential AT1-EXP3174;
. Ž 100 nmolrl and D8731; 1 mmolrl , AT -PD123177; 100 
Effect of AII on thrombin-induced responses
Due to the known difficulties in quantifying thrombin receptor protein levels in non-transfected VSMC using standard techniques, such as Western blotting, FACS analysis, or immunohistochemistry, we determined the thrombin-induced release of 6-keto-PGF as an index of func1a tionally active thrombin receptors in VSMC. In unstimulated VSMC, the basal release of 6-keto-PGF was below 
Effect of PKC and tyrosine kinase inhibitors
Using inhibitors of various protein kinases, we investigated the signalling pathway involved in the AII-induced increase in thrombin receptor mRNA expression in VSMC.
Ž . The AII 100 nmolrl, 2 h -mediated increase in thrombin receptor mRNA expression was enhanced by the PKC Ž . inhibitor Ro 31-8220 100 nmolrl and the non-specific Ž . kinase inhibitor staurosporine 10 nmolrl, Fig. 6A . Neither of the inhibitors used exerted significant effects on thrombin receptor mRNA levels in the absence of AII Ž . data not shown .
Prolonged incubation of VSMC with phorbol myristate Ž . acetate PMA, 0.3 mmolrl, 24 h to down-regulate PKC enzymes, did not alter the AII-induced increase in throm-Ž . bin receptor mRNA expression data not shown . The Ž . tyrosine kinase inhibitors genistein 10 mmolrl and erb-Ž .
c-src statin A 10 mmolrl, Fig. 6B , the specific pp60 Ž . inhibitor PP1 100 nmolrl and the mitogen activated Ž . Ž . protein MAP kinase inhibitor PD98059 50 mmolrl also failed to affect the AII-mediated increase in thrombin Ž . receptor mRNA Fig. 6C .
Effect of AII on thrombin receptor expression in the rat aorta
The effect of AII on the expression of thrombin receptor mRNA in endothelium-denuded rat aortic rings was determined using semi-quantitative RT-PCR. Under the Ž . experimental conditions used, AII 100 nmolrl, 2 or 6 h Fig. 7 . The expression of GAPDH was taken as an internal standard for the PCR as AII was shown not to affect GAPDH mRNA levels in Northern Ž . blot experiments data not shown .
To verify that the increase in thrombin receptor mRNA expression was associated with an increase in the expression of functional thrombin receptors, the contractile response of endothelium-denuded aortic rings to thrombin was assessed. While preincubation of rat aortic rings with Ž . AII 100 nmolrl; 8 h did not affect contractions obtained Ž . Ž to either KCl 80 mmolrl or phenylephrine 1 nmolrl to . Ž 1 mmolrl; not shown the response to thrombin 5 and 10
. Ž Urml was enhanced by 290 and 410%, respectively 
Discussion
In the present study, we have demonstrated that in both native and cultured VSMC, AII increases the expression of thrombin receptor mRNA. In cultured VSMC, this effect is mediated by activation of AT receptors and an intra-1 cellular signalling pathway negatively regulated by PKC. Moreover, despite the lack of a direct evidence that thrombin receptor protein was increased, we were able to show that AII significantly increased the thrombin-induced release of 6-keto-PGF , and the thrombin-induced contrac1a tion of endothelium-denuded rings. Both findings are indicative of an enhanced expression of functional thrombin receptors.
Using molecular cloning and sequencing techniques, three different AII receptor subtypes have been identified to-date. The effects of AII on vasoconstriction and mitogenesis in vascular cells has been ascribed, almost excluw x sively, to the activation of the AT receptor 8,20 , whereas 1 the AT receptor, which is reportedly coupled to an in-2 crease in tyrosine phosphatase activity, appears to be mainly involved in developmental and neuronal responses w x to AII 21 . Somewhat paradoxically, an anti-proliferative action of AII mediated by the AT receptor has been 2 w x described in microvascular endothelial cells 22 . No physiological role for the AT receptor subtype has been 3 w x described to date 23 . Since, in the present study, the AII-induced increase in thrombin receptor, c-fos mRNA expression and the tyrosine phosphorylation of MAP ki-Ž . nase data not shown were unaffected by either the AT 2 receptor antagonist PD123177 or the specific ligand CGP42112A, but were significantly attenuated in the presence of the AT receptor antagonists EXP3174 or D8731, bin receptor in the aorta and to enhance thrombin-induced w x contraction of endothelium-denuded aortic rings 24 . These effects were also reversed by the AT antagonist, losartan. 1 The AT receptor is a G-protein-coupled receptor and 1 the binding of AII activates phospholipases and subse-Ž w x. quently PKC for reviews see 25, 26 . There is an increasing amount of evidence suggesting that following their occupancy, G-protein-coupled receptors, which are devoid of inherent protein tyrosine kinase activity, can also rapidly induce tyrosine phosphorylation of cellular substrate proteins as well as of the receptors themselves. For example, mutation of conserved intramembrane tyrosine residues in the AT receptor prevents its coupling to G-proteins as 1A Ž . well as the subsequent activation of phospholipase C PLC w x 27,28 . In VSMC, in which AII is able to activate tyrosine w x kinase pathways and cause contraction 29 , a fusion protein, comprising the intracellular tail of the AT receptor, 1 was found to be an excellent substrate for the src family of w x protein tyrosine kinases 30 . This phenomenon, at least in the case of the AT receptor, was shown to be linked to the 1 tyrosine phosphorylation of PLC-g1 and to a subsequent increase in the formation of inositol 1,4,5-trisphosphate w x 31 . Despite evidence suggesting a role for tyrosine kinases in the intracellular signalling pathways activated following occupation of the AT receptor, the AII-media-1 ted increase in thrombin receptor mRNA was insensitive to genistein, erbstatin A and PP1 and therefore does not appear to involve tyrosine kinase activation. However, it cannot be excluded that tyrosine kinases, which are insensitive to the inhibitors used, are involved in mediating the AII-induced response. The lack of effect of genistein on this pathway also implies that neither the activation of the Ž . Janus-like kinase JAK nor the STAT-pathway, both of w x which are highly sensitive to genistein 32 , are likely to be involved in transducing the effect of AT receptor activa-1 tion under the experimental conditions studied. Moreover, although a PD98059-sensitive tyrosine phosphorylation and activation of MAP kinases was observed in VSMC follow-Ž . ing stimulation with AII data not shown , this compound failed to influence the AII-induced increase in thrombin receptor mRNA. Thus, the activation of MAP kinases cannot be implicated in the signalling pathway leading to enhanced thrombin receptor expression.
Inhibition of PKC using either Ro 31-8220 or staurosporine enhanced the AII-mediated increase in thrombin receptor mRNA suggesting that PKC negatively regulates this signalling process. This observation is not unusual in AII-stimulated cells since PKC has also been reported to w x be a negative feedback regulator of PLC in VSMC 33 and signal transduction from the receptor to the G-protein w x in mesangial cells 34 . The lack of effect of PKC downregulation by long-term treatment with PMA does not preclude a role for PKC in the AII-mediated regulation of Ž thrombin receptor expression since atypical isoforms e.g.
. PKC-l and -z do not bind diacylglycerol or phorbol w x esters 35 .
We have previously demonstrated that 5-HT increases expression of the thrombin receptor in VSMC via a pathway sensitive to genistein and erbstatin A as well as w x inhibitors of PKC 18 . It would therefore appear that the initial components of the signalling pathways which ultimately culminate in enhanced thrombin receptor expression are highly dependent on the type of receptor activated. Whether distal signalling pathways initiated by AII and 5-HT converge to enhance the transcription of the gene encoding the thrombin receptor or to change mRNA stability remains to be clarified. Some experimental observa-Ž . tions suggest, that repressor sequence s may be present within the distal 5 X -region of the thrombin receptor gene enhancer. Indeed, functional analysis demonstrated a markedly lower transcriptional activity of the full-length X w x thrombin receptor promoter than a 5 -truncated form 36 .
In certain cell systems, the growth-promoting effects of AII have been shown to be mediated via the increased expression of autocrine growth factors, such as PDGF , AA w x transforming growth factor-b1 or bFGF 37,38 , factors which also enhance the expression of the thrombin recepw x tor mRNA in VSMC 17,39 . However, the effect of AII on the expression of thrombin receptor mRNA described in the present study is unlikely to involve the production of growth factors. Indeed, AT receptor activation increased 1 thrombin receptor mRNA expression within 1 h whereas the AII-stimulated production of PDGF etc. is generally w x regarded as a delayed response 40,41 .
As the effect described here was observed in native and cultured VSMC, it is more than likely that AII is able to contribute to the enhanced expression of the thrombin receptor in smooth muscle cells within the human atherow x sclerotic plaques 16 . This increase in expression of the thrombin receptor could facilitate the mitogenic activity of thrombin. Moreover, since the activity of thrombin results not only in acute thrombus formation, but also in the stimulation of the secretion of platelet-derived vasoactive w x factors 42 , it is conceivable that the effects of vascular injury on the up-regulation of the thrombin receptor are maintained partly as a consequence of the co-operative activity of a series of growth factors. Such effects could theoretically result from either the amplification of intracellular signalling pathways or the cross-talk betweenrcoactivation of certain receptors. For example, the activation of the AII and thrombin receptors has been reported to w x induce a transactivation of the PDGF-b receptor 43 .
In summary, we have demonstrated that AII, via activation of the AT receptor on both native and cultured 1 VSMC, enhances expression of thrombin receptor mRNA and potentiates the functional response to thrombin receptor activation via a signalling pathway negatively regulated by a PMA-insensitive isoform of PKC. Although the concentrations of AII used here on cultured VSMC were relatively high, it is tempting to speculate that as the local concentration of AII and the thrombin receptor are known to increase at sites of vascular injury as well as within the at Pennsylvania State University on February 20, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from ( )w x atherosclerotic plaque 16,17 the mechanism herein described may promote the proliferation of VSMC by ensuring the de novo generation of the thrombin receptor and thereby facilitating the mitogenic activity of thrombin.
